Movers & Shakers - Spark Newswire

1 minute read

Lexicon Shares Jump 20 Percent Following Positive Results From Mid-Stage Diabetic Neuropathy Study

Today, 11:22 PM

Lexicon Pharmaceuticals (NASDAQ: LXRX) reported positive topline results from the Phase 2 proof-of-concept study of its lead candidate LX9211 in painful diabetic neuropathy. The RELIEF-DPN-1 is the first of two Phase 2 proof-of-concept study designed to evaluate LX9211 in patients with neuropathic pain.

LXRX

1 minute read

Icosavax Shares Plummet Following Interim Results From Initial-Stage RSV Vaccine Study

By Ragothaman Srinivasan

Today, 11:22 PM

Icosavax (NASDAQ: ICVX) announced interim results from its Phase 1/1b clinical trial of IVX-121, respiratory syncytial virus (RSV) F antigen, in young and older adults. The Phase 1/1b clinical trial is designed to evaluate the safety and immunogenicity of three dose levels of IVX-121.

ICVX

1 minute read

Kezar Life Shares Shoot Higher After Positive Results From Mid-Stage Study Of Kidney Disease Candidate

By Ragothaman Srinivasan

Today, 11:22 PM

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

KZR

2 minute read

Cannabis Movers & Shakers: 22nd Century Group, Houseplant, Proven Media

By Jelena Martinovic

Today, 11:22 PM

22nd Century Group Names New CFO 22nd Century Group (NASDAQ: XXII) has appointed f R. Hugh Kinsman to oversee its financial department. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022.

XXII

3 minute read

Cannabis Movers & Shakers: The Parent Co, Sensi Media, 4Front Ventures, BellRock Brands

By Jelena Martinovic

Today, 11:22 PM

The Parent Co. Welcomes Roz Lipsey To Its Leadership Team TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF), which is doing business as The Parent Co., has tapped Roz Lipsey to serve as executive vice president of operations and wholesale.

AGFY

2 minute read

ICYMI: 5 Things You Might Not Know About Jeff Bezos

By Chris Katje

Today, 11:22 PM

This story was originally published in April 2021.

AMZN

1 minute read

DBV Technologies’ Shares Shoot Higher As Positive Results From Late-Stage Study Of Peanut Allergy In Toddlers Met Primary Endpoint

By Ragothaman Srinivasan

Today, 11:22 PM

DBV Technologies (NASDAQ: DBVT) announced positive topline results from EPITOPE study of its drug candidate Viaskin Peanut 250 µg for the treatment of peanut-allergic toddlers ages 1 to 3 years.

DBVT

1 minute read

Novavax Shares Gain Following FDA Advisory Committee’s Positive Vote On Emergency Use Authorization (EUA) For COVID-19 Vaccine

By Ragothaman Srinivasan

Today, 11:22 PM

Novavax’s (NASDAQ: NVAX) COVID-19 vaccine (NVX-CoV2373) receives positive vote from U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee (VRBPAC), recommending FDA to grant Emergency Use Authorization (EUA) for individuals aged 18 years and over.

NVAX